Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-02-14 1:56 pm Sale | 13G | GenMark Diagnostics Inc. GNMK | Consonance Capital Management LP | 0 0.000% | -4,480,163 (Position Closed) | View |
2021-05-10 11:58 am Sale | 13G | GenMark Diagnostics Inc. GNMK | WASATCH ADVISORS LP | 0 0.000% | -9,339,226 (Position Closed) | View |
2021-04-12 1:05 pm Sale | 13G | GenMark Diagnostics Inc. GNMK | FMR LLC | 79,997 0.108% | -10,678,662 (-99.26%) | View |
2021-03-26 09:07 am Purchase | 13D | GenMark Diagnostics Inc. GNMK | Magnetar Financial LLC | 4,221,792 5.740% | 4,221,792 (New Position) | View |
2021-02-17 3:11 pm Sale | 13G | GenMark Diagnostics Inc. GNMK | Consonance Capital Management LP | 4,480,163 6.250% | -1,578,342 (-26.05%) | View |
2021-02-16 4:07 pm Purchase | 13G | GenMark Diagnostics Inc. GNMK | Redmile Group LLC | 4,537,400 6.300% | 4,537,400 (New Position) | View |
2021-02-16 2:21 pm Purchase | 13G | GenMark Diagnostics Inc. GNMK | Consonance Capital Management LP | 6,058,505 9.990% | 6,058,505 (New Position) | View |
2021-02-12 4:09 pm Sale | 13G | GenMark Diagnostics Inc. GNMK | CADIAN CAPITAL MANAGEMENT LP | 0 0.000% | -5,517,767 (Position Closed) | View |
2021-02-10 10:57 am Purchase | 13G | GenMark Diagnostics Inc. GNMK | VANGUARD GROUP INC | 4,497,904 6.270% | 1,334,109 (+42.17%) | View |
2021-02-09 2:35 pm Purchase | 13G | GenMark Diagnostics Inc. GNMK | WASATCH ADVISORS LP | 9,339,226 13.000% | 9,339,226 (New Position) | View |
2021-02-08 10:23 am Purchase | 13G | GenMark Diagnostics Inc. GNMK | FMR LLC | 10,758,659 15.000% | 2,049,602 (+23.53%) | View |
2021-01-29 09:56 am Purchase | 13G | GenMark Diagnostics Inc. GNMK | BlackRock Inc. BLK | 5,623,577 7.800% | 1,333,750 (+31.09%) | View |
2020-05-18 4:18 pm Sale | 13D | GenMark Diagnostics Inc. GNMK | Casdin Capital LLC | 2,555,000 4.100% | -810,000 (-24.07%) | View |
2020-05-07 4:26 pm Sale | 13G | GenMark Diagnostics Inc. GNMK | MORGAN STANLEY MS | 7,412 0.000% | -5,145,918 (-99.86%) | View |
2020-02-14 1:30 pm Sale | 13G | GenMark Diagnostics Inc. GNMK | PRICE T ROWE ASSOCIATES INC | 2,113,579 3.600% | -2,924,172 (-58.05%) | View |
2020-02-13 4:18 pm Purchase | 13G | GenMark Diagnostics Inc. GNMK | MORGAN STANLEY MS | 5,153,330 8.900% | 2,097,409 (+68.63%) | View |
2020-02-13 4:06 pm Purchase | 13G | GenMark Diagnostics Inc. GNMK | CADIAN CAPITAL MANAGEMENT LP | 5,517,767 9.500% | 509,645 (+10.18%) | View |
2020-02-11 4:44 pm Purchase | 13G | GenMark Diagnostics Inc. GNMK | VANGUARD GROUP INC | 3,163,795 5.440% | 3,163,795 (New Position) | View |
2020-02-07 4:11 pm Sale | 13D | GenMark Diagnostics Inc. GNMK | Casdin Capital LLC | 3,365,000 5.800% | -485,000 (-12.60%) | View |
2020-02-07 11:20 am Purchase | 13G | GenMark Diagnostics Inc. GNMK | FMR LLC | 8,709,057 14.994% | 315,765 (+3.76%) | View |